ASSUMPTA NNAJI: Open Payments
NPI 1104450691 · FOSTORIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 18 payments from 10 companies in 2025. Trend: 2023 $1,036 · 2024 $1,452 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $191 |
| Alnylam Pharmaceuticals Inc. | 1 | $118 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| PFIZER INC. | 1 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
| Aimmune Therapeutics, Inc. | 1 | $61 |
| Novo Nordisk Inc | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: VRAYLAR, AMVUTTRA, PAXLOVID, Kerendia, ZENPEP, Ozempic, CAPLYTA, Auvelity.
Industry payments across OH — which companies pay providers there.
